FDA OKs Subcutaneous Mosunetuzumab for Follicular LymphomaJanuary 6, 2026Lymphoma & Plasma Cell DisordersFDA Actions
Agent Orange Exposure Increases Lymphoma Risk in Million Veteran Program CohortNovember 11, 2025OncologyLymphoma & Plasma Cell DisordersMultiple Myeloma
Agent Orange Exposure and Genetic Factors Independently Raise Risk for Multiple Lymphoma TypesAugust 25, 2025Lymphoma & Plasma Cell DisordersHematologyLeukemia, Myelodysplasia, TransplantationOncology
New Cancer Drugs: Do Patients Prefer Faster Access or Clinical Benefit?December 12, 2024Mixed TopicsBreast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell Disorders
New Cancer Vaccines on the Horizon: Renewed Hope or Hype?December 6, 2024Mixed TopicsOncologyGenitourinary CancerMelanomaLymphoma & Plasma Cell DisordersLung Cancer
Inside the Patient-Oncologist Bond: Why It’s Often So StrongDecember 2, 2024Breast CancerMixed TopicsGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell Disorders
Outpatient CAR T: Safe, Effective, AccessibleNovember 4, 2024Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaMixed TopicsOncologyHematology
Cannabis in Cancer: What Oncologists and Patients Should KnowOctober 23, 2024Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
Risk Assessment Tool Can Help Predict Fractures in CancerOctober 21, 2024Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerMelanomaLymphoma & Plasma Cell Disorders
Cancer Risk: Are Pesticides the New Smoking?September 20, 2024OncologyBreast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell Disorders
The OCTAGON Project: A Novel VA-Based Telehealth Intervention for Oral Chemotherapy MonitoringSeptember 12, 2024Prostate CancerOncologyLung CancerLymphoma & Plasma Cell Disorders
Influence of Patient Demographics and Facility Type on Overall Survival in Sezary SyndromeSeptember 10, 2024OncologyLymphoma & Plasma Cell Disorders
Male Patient With a History of Monoclonal B Cell Lymphocytosis Presenting with Breast Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Case Report and Literature ReviewSeptember 10, 2024OncologyLymphoma & Plasma Cell Disorders
